CA3223733A1 - A process for the synthesis of 4-((r)-2-{[6-((s)-3-methoxy-pyrrolidin-1-yl)-2-phenyl- pyrimidine-4-carbonyl]-amino}-3-phosphono-propionyl)-piperazine-1 -carboxylic acid butyl ester - Google Patents
A process for the synthesis of 4-((r)-2-{[6-((s)-3-methoxy-pyrrolidin-1-yl)-2-phenyl- pyrimidine-4-carbonyl]-amino}-3-phosphono-propionyl)-piperazine-1 -carboxylic acid butyl ester Download PDFInfo
- Publication number
- CA3223733A1 CA3223733A1 CA3223733A CA3223733A CA3223733A1 CA 3223733 A1 CA3223733 A1 CA 3223733A1 CA 3223733 A CA3223733 A CA 3223733A CA 3223733 A CA3223733 A CA 3223733A CA 3223733 A1 CA3223733 A1 CA 3223733A1
- Authority
- CA
- Canada
- Prior art keywords
- compound
- process according
- hci
- mixture
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EPPCT/EP2021/069486 | 2021-07-13 | ||
| EP2021069486 | 2021-07-13 | ||
| PCT/EP2022/069238 WO2023285342A2 (en) | 2021-07-13 | 2022-07-11 | A process for the synthesis of 4-((r)-2-{[6-((s)-3-methoxy-pyrrolidin-1-yl)-2-phenyl- pyrimidine-4-carbonyl]-amino}-3-phosphono-propionyl)-piperazine-1 -carboxylic acid butyl ester |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3223733A1 true CA3223733A1 (en) | 2023-01-19 |
Family
ID=82748669
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3223733A Pending CA3223733A1 (en) | 2021-07-13 | 2022-07-11 | A process for the synthesis of 4-((r)-2-{[6-((s)-3-methoxy-pyrrolidin-1-yl)-2-phenyl- pyrimidine-4-carbonyl]-amino}-3-phosphono-propionyl)-piperazine-1 -carboxylic acid butyl ester |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240317784A1 (https=) |
| EP (1) | EP4370525A2 (https=) |
| JP (1) | JP2024524658A (https=) |
| KR (1) | KR20240033005A (https=) |
| CN (1) | CN117616033A (https=) |
| CA (1) | CA3223733A1 (https=) |
| IL (1) | IL309948A (https=) |
| MX (1) | MX2024000653A (https=) |
| TW (1) | TW202317140A (https=) |
| WO (1) | WO2023285342A2 (https=) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2225253B1 (en) * | 2007-11-29 | 2012-06-27 | Actelion Pharmaceuticals Ltd. | Phosphonic acid derivates and their use as p2y12 receptor antagonists |
| EP3515924B1 (en) * | 2016-09-22 | 2021-12-15 | Idorsia Pharmaceuticals Ltd | Crystalline forms |
| MA49887A (fr) | 2017-03-15 | 2020-06-24 | Idorsia Pharmaceuticals Ltd | Administration sous-cutanée d'un antagoniste du récepteur p2y12 |
-
2022
- 2022-07-11 MX MX2024000653A patent/MX2024000653A/es unknown
- 2022-07-11 JP JP2024501708A patent/JP2024524658A/ja active Pending
- 2022-07-11 US US18/579,110 patent/US20240317784A1/en active Pending
- 2022-07-11 KR KR1020247004672A patent/KR20240033005A/ko active Pending
- 2022-07-11 WO PCT/EP2022/069238 patent/WO2023285342A2/en not_active Ceased
- 2022-07-11 EP EP22748321.1A patent/EP4370525A2/en active Pending
- 2022-07-11 CA CA3223733A patent/CA3223733A1/en active Pending
- 2022-07-11 CN CN202280048853.5A patent/CN117616033A/zh active Pending
- 2022-07-11 IL IL309948A patent/IL309948A/en unknown
- 2022-07-12 TW TW111126010A patent/TW202317140A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024524658A (ja) | 2024-07-05 |
| KR20240033005A (ko) | 2024-03-12 |
| IL309948A (en) | 2024-03-01 |
| WO2023285342A3 (en) | 2023-04-13 |
| WO2023285342A2 (en) | 2023-01-19 |
| TW202317140A (zh) | 2023-05-01 |
| CN117616033A (zh) | 2024-02-27 |
| EP4370525A2 (en) | 2024-05-22 |
| US20240317784A1 (en) | 2024-09-26 |
| MX2024000653A (es) | 2024-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11952341B2 (en) | Method of preparing high chiral purity lactam intermediate and brivaracetam | |
| EP0595345B1 (en) | Process for producing alanylglutamine | |
| KR101404893B1 (ko) | 트랜스-4-［［(5ｓ)-5-［［［3,5-비스(트리플루오로메틸)페닐］메틸］ (2-메틸-2ｈ-테트라졸-5-일)아미노］-2,3,4,5-테트라히드로-7,9-디메틸-1ｈ-1-벤즈아제핀-1-일］메틸］-시클로헥산카르복실산 | |
| CN107922352B (zh) | 制备蛋白质脱乙酰酶抑制剂的方法 | |
| EP0430336B1 (en) | Process for the preparation of 4-O-phosphates of dopamine and dopamine derivatives | |
| CZ2014502A3 (cs) | Nová forma sofosbuviru a způsob její přípravy | |
| JP7365349B2 (ja) | 一酸化窒素を供与するプロスタグランジン類似体の製造方法 | |
| US5831086A (en) | Production of cefotaxime and new sodium salts | |
| CA3223733A1 (en) | A process for the synthesis of 4-((r)-2-{[6-((s)-3-methoxy-pyrrolidin-1-yl)-2-phenyl- pyrimidine-4-carbonyl]-amino}-3-phosphono-propionyl)-piperazine-1 -carboxylic acid butyl ester | |
| BG63721B1 (bg) | Метод за получаване на валацикловир и релевантни междинни продукти | |
| WO2013177713A1 (en) | Process for preparation of an antifolate agent | |
| US20240262805A1 (en) | Method for producing compound or pharmaceutically acceptable salt thereof | |
| TWI826724B (zh) | 用以製造1,5-苯并噻氮呯化合物之方法 | |
| US5220002A (en) | Deacetylcolchicine derivatives | |
| EP3658569B1 (en) | Process and intermediates for synthesis of peptide compounds | |
| WO2008097483A2 (en) | Methods for preparing aryl-substituted ketophosphonates | |
| EP0262202B1 (en) | Method for preparing penicillanic acid derivatives | |
| CN111808040A (zh) | 多构型2-氧代噁唑烷-4-羧酸类化合物的合成方法 | |
| KR860000586B1 (ko) | 트리아진 유도체의 제조방법 | |
| KR20040105791A (ko) | 트리테르펜 유도체의 제조 방법 | |
| CN101492431A (zh) | 马来酸桂哌齐特的制备方法 | |
| WO2025257773A1 (en) | Processes for the preparation of ritlecitinib and intermediates thereof | |
| HK40111936A (en) | Method for producing compound or pharmaceutically acceptable salt thereof | |
| SU891662A1 (ru) | Способ получени карбометоксипроизводных 5(4)-аминоимидазол-4(5)-карбоксамида | |
| RU1772103C (ru) | Способ получени 2-аминобензонитрила |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 2ND ANNIV.) - STANDARD Year of fee payment: 2 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD Year of fee payment: 3 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250701 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250701 |